Chemical–genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy

Author:

Koh Eun-Ik1ORCID,Oluoch Peter O.1,Ruecker Nadine2,Proulx Megan K.1,Soni Vijay2,Murphy Kenan C.1,Papavinasasundaram Kadamba1ORCID,Reames Charlotte J.1ORCID,Trujillo Carolina2,Zaveri Anisha2,Zimmerman Matthew D.3,Aslebagh Roshanak45,Baker Richard E.1,Shaffer Scott A.45ORCID,Guinn Kristine M.6,Fitzgerald Michael7,Dartois Véronique38ORCID,Ehrt Sabine2ORCID,Hung Deborah T.7910,Ioerger Thomas R.11,Rubin Eric J.6,Rhee Kyu Y.2,Schnappinger Dirk2,Sassetti Christopher M.1ORCID

Affiliation:

1. Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01655

2. Department of Microbiology and Immunology, Weill Cornell Medical College, New York, NY 10065

3. Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110

4. Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01655

5. Mass Spectrometry Facility, University of Massachusetts Medical School, Shrewsbury, MA 01545

6. Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115

7. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142

8. Department of Medical Sciences, Hackensack School of Medicine, Nutley, NJ 07110

9. Center for Computation and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114

10. Department of Genetics, Harvard Medical School, Boston, MA 02114

11. Department of Computer Science and Engineering, Texas A&M University, College Station, TX 77840

Abstract

Significance Efforts to improve tuberculosis therapy include optimizing multidrug regimens to take advantage of drug–drug synergies. However, the complex host environment has a profound effect on bacterial metabolic state and drug activity, making predictions of optimal drug combinations difficult. In this study, we leverage a newly developed library of conditional knockdown Mycobacterium tuberculosis mutants in which genetic depletion of essential genes mimics the effect of drug therapy. This tractable system allowed us to assess the effect of growth condition on predicted drug–drug interactions. We found that these interactions can be differentially sensitive to the metabolic state, and select in vitro–defined interactions can be leveraged to accelerate bacterial killing during infection. These findings suggest strategies for optimizing tuberculosis therapy.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference67 articles.

1. Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation

2. Short-course chemotherapy for pulmonary tuberculosis;Fox W.;Am. Rev. Respir. Dis.,1975

3. World Health Organization, Guidelines for Treatment of Tuberculosis (World Health Organization, ed. 4, 2010).

4. World Health Organization, Global Tuberculosis Report 2020 (World Health Organization, 2020).

5. Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3